Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Alcohol Drinking 10Smoking Cessation 4Neoplasms 4Smoking 2Postoperative Complications 2Pain 2Depression 2Condylomata Acuminata 2Cardiovascular Diseases 2Agnosia 2Wounds and Injuries 1Warts 1Visceral Pain 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1Tuberculosis 1Thyroid Cancer, Papillary 1Substance-Related Disorders 1Squamous Cell Carcinoma of Head and Neck 1Social Isolation 1Risk-Taking 1Risk Reduction Behavior 1Patient Preference 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pancreatic Intraductal Neoplasms 1Pancreatic Cyst 1Obesity 1Mouth Neoplasms 1Motor Activity 1

Interventions

Radiofrequency Ablation 2Interviews as Topic 2dabrafenib 1Thyroxine 1Thyroid (USP) 1Robotic Surgical Procedures 1Iodine-131 1Gefitinib 1Ferrosoferric Oxide 1Ethanol 1Digoxin 1Decision Support Techniques 1Counseling 1Conversion to Open Surgery 1Administration, Cutaneous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Thyroid Cancer, Papillary × Ethanol × Clear all
NCT01974284 2019-11-25

Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

Yale University

Phase NA Terminated
7 enrolled 4 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡